Dr. Raghavan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3506 W Tyvola Rd
4th Floor Med Specialty Clinic
Charlotte, NC 28208Phone+1 704-816-9000
Summary
- Dr. Derek Raghavan is an oncologist in Charlotte, NC and is affiliated with W. G. (Bill) Heffner Veterans Affairs Medical Center. He received his medical degree from University of Sydney Faculty of Medicine and has been in practice 43 years. He is experienced in chemotherapy, testicular neoplasms, germ cell tumors, prostate cancer, and cystectomy. He has more than 300 publications and over 4000 citations
Education & Training
University of SydneyMD (research), Biology of bladder cancer - thesis produced, 2011 - 2012- University of LondonPhD, Experimental Pathology, 1978 - 1980
University of Sydney Faculty of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 2002 - 2026
OH State Medical License 2005 - 2026
NC State Medical License 2020 - 2022- Royal Australasian College of PhysiciansFellow
Awards, Honors, & Recognition
- World Affairs Council Citizen of the Year World Affairs Council of Charlotte, 2019
- Charlotte Business Journal Physician of the Year Charlotte Business Journal, 2013
- Fellow (FAAAS) American Association for the Advancement of Science, 2010
- Join now to see all
Clinical Trials
- S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Start of enrollment: 2001 Jul 01
- Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy Start of enrollment: 2004 Dec 01
Publications & Presentations
PubMed
- 5 citationsAdjuvant systemic therapy of prostate cancer.Derek Raghavan
Seminars in Oncology. 1995-12-01 - 360 citationsRandomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer With...Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Iwona Skoneczna, Maria De Santis
Journal of Clinical Oncology. 2012-04-01 - 1937 citationsNeoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerH. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang
The New England Journal of Medicine. 2003-08-28
Other
- Genetic Anticipation and MentorshipDerek Raghavan, MD, Healio
https://www.doximity.com/articles/c07933d2-b1c2-46c6-b96e-ab0fc31b35af
UpToDate, Wolters Kluwer Health - 2012-09-10
Authored Content
- Not Sure How Much More Breathless Enthusiasm I Can TakeOctober 2020
Press Mentions
Accomplished Researcher to Lead Atrium Cancer Programs in Winston-Salem, CharlotteDecember 15th, 2022- Medication vs Meals: The Affected Person Care Dilemma of ‘Monetary Toxicity’December 2nd, 2022
- Medicine vs Food: The Patient Care Dilemma of ‘Financial Toxicity’November 17th, 2022
- Join now to see all
Professional Memberships
- Fellow
- American Association for the Advancement of Science (AAAS)Fellow
- Royal Australasian College of Physicians (RACP)Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
